| |
Appointment of Managing Director International
May 14, 2013
|
102.4 KB |
|
| |
Appointment of Managing Director International
May 13, 2013
|
54.3 KB |
|
| |
Quarterly Report on Form 10-Q
May 9, 2013
|
234.8 KB |
|
| |
Appendix 4C - quarterly
Apr 30, 2013
|
208.8 KB |
|
| |
Proxy Statement for 2013 AGM
Apr 19, 2013
|
834.6 KB |
|
| |
ReZolve2 Clinical Trial Initiation
Mar 28, 2013
|
54.7 KB |
|
| |
ReZolve2 Clinical Trial Initiation
Mar 28, 2013
|
60.3 KB |
|
| |
Form S-8 Filed with SEC
Feb 28, 2013
|
120.7 KB |
|
| |
Notice of Briefing Call and Cowen HC Conference Presentation
Feb 28, 2013
|
49.4 KB |
|
| |
Preliminary Final Report
Feb 28, 2013
|
1.0 MB |
|
 |
REVA Medical to Hold Briefing Call on Financial Results for 2012 and Present at Cowen Health Care Conference
Feb 27, 2013
|
35.2 KB |
|
| |
SAN DIEGO, Feb. 27, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through December 31, 2012 and its business outlook. Robert Stockman, Chairman and CEO, will host the call.
The call is scheduled for 2:00 p.m. US PST on Tuesday, March 5, ...
|
| |
Presentation at CRT Conference
Feb 21, 2013
|
70.7 KB |
|
 |
REVA to Present at CRT 2013 Conference
Feb 20, 2013
|
37.5 KB |
|
| |
SAN DIEGO, Feb. 20, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that its Chief Operating Officer, Robert K. Schultz, PhD, is presenting at the Cardiovascular Research Technologies Conference at 2:25 p.m. US EST on Monday, February 25, 2013. The conference is being held February 23 through 2...
|
| |
Letter to Shareholders
Feb 7, 2013
|
232.2 KB |
|
| |
Appendix 3B
Feb 4, 2013
|
223.0 KB |
|
| |
Appendix 4C - quarterly
Jan 31, 2013
|
205.9 KB |
|
| |
Appendix 3B
Jan 22, 2013
|
217.3 KB |
|
| |
Release of Securities from Mandatory Escrow
Jan 22, 2013
|
58.6 KB |
|
| |
Presentation at J.P. Morgan Conference
Jan 11, 2013
|
3.5 MB |
|
| |
REVA to Present at 31st Annual J.P. Morgan Healthcare Conference
Jan 3, 2013
|
51.1 KB |
|
|
|